NASDAQ:KOOL Cesca Therapeutics (KOOL) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free KOOL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$9.58▼$9.6650-Day Range$2.11▼$5.1452-Week Range$2.10▼$7.00Volume72,813 shsAverage Volume112,188 shsMarket Capitalization$23.15 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Cesca Therapeutics alerts: Email Address Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story About Cesca Therapeutics Stock (NASDAQ:KOOL)Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.Read More Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story KOOL Stock News HeadlinesAugust 12, 2023 | nj.comNew book by Kool & the Gang member; Junior Police Academy a success | Journal EntriesJune 5, 2023 | msn.comSolo artist Cesca ‘happy’ to team up with BGYO’s MikkiApril 18, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereMarch 25, 2023 | msn.com'Maybe Next Time' adaptation: All we know about Apple Studios and Cesca Major movieApril 29, 2022 | yahoo.comCesca Chairs Are Our Latest (But Oldest) Design ObsessionMarch 21, 2022 | msn.comCesca’s ‘Pambihirang Harana’ song aims to normalize girls initiating relationshipsSee More Headlines Receive KOOL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cesca Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2018Today4/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Laboratory Apparatus & Furniture Sub-IndustryN/A Current SymbolNASDAQ:KOOL CUSIPN/A CIK811212 Webwww.cescatherapeutics.com Phone916-858-5100FaxN/AEmployees53Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-39,720,000.00 Net Margins-98.84% Pretax MarginN/A Return on Equity-77.30% Return on Assets-37.75% Debt Debt-to-Equity Ratio0.50 Current Ratio1.52 Quick Ratio0.91 Sales & Book Value Annual Sales$9.67 million Price / Sales2.40 Cash FlowN/A Price / Cash FlowN/A Book Value$3.11 per share Price / Book3.09Miscellaneous Outstanding Shares2,416,000Free FloatN/AMarket Cap$23.20 million OptionableNot Optionable Beta1.07 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Xiaochun Xu M.B.A. (Age 48)Ph.D., Chairman, CEO & Pres Mr. Jeff Cauble (Age 46)Principal Financial & Accounting Officer Mr. James Xu J.D. (Age 48)L.L.M., M.B.A., Director, Gen. Counsel, Sr. VP of Legal Affairs & Cybersecurity and Corp. Sec. Mr. Philip H. Coelho (Age 75)Chief Technology Officer Ms. Haihong ZhuPres of ThermoGenesisKey CompetitorsIndaptus TherapeuticsNASDAQ:INDPOncternal TherapeuticsNASDAQ:ONCTCytoMed TherapeuticsNASDAQ:GDTCCue HealthNASDAQ:HLTHBullfrog AINASDAQ:BFRGView All Competitors KOOL Stock Analysis - Frequently Asked Questions How were Cesca Therapeutics' earnings last quarter? Cesca Therapeutics Inc (NASDAQ:KOOL) issued its earnings results on Monday, May, 14th. The biotechnology company reported ($0.27) earnings per share for the quarter. The biotechnology company earned $1.87 million during the quarter. Cesca Therapeutics had a negative net margin of 98.84% and a negative trailing twelve-month return on equity of 77.30%. What other stocks do shareholders of Cesca Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cesca Therapeutics investors own include CTI BioPharma (CTIC), SCYNEXIS (SCYX), NVIDIA (NVDA), QUALCOMM (QCOM), Anavex Life Sciences (AVXL), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AbbVie (ABBV), Aldeyra Therapeutics (ALDX) and Advanced Micro Devices (AMD). This page (NASDAQ:KOOL) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressThe “Perfect Storm” for GoldGold Safe ExchangeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.